(Q30353815)

20 June 2017

title

Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK. (English)

1 reference

20 June 2017

1 reference

Beate Sander

1

0 references

Frederick G Hayden

series ordinal

2

object named as

Frederick G Hayden

1 reference

20 June 2017

Marlene Gyldmark

3

1 reference

20 June 2017

Louis P Garrison

series ordinal

4

1 reference

20 June 2017

publication date

1 January 2006

1 reference

20 June 2017

1 reference

20 June 2017

volume

24

1 reference

20 June 2017

issue

4

1 reference

20 June 2017

page(s)

373-386

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200624040-00007

20 June 2017

exact match

0 references

cites work

Influenza vaccinations: who needs them and when?

1 reference

12 December 2020

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

12 December 2020

Perspectives on antiviral use during pandemic influenza

1 reference

12 December 2020

Influenza-associated hospitalizations in the United States

1 reference

12 December 2020

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

1 reference

12 December 2020

Patient characteristics determine differences in the influenza vaccination rate more so than practice features

1 reference

12 December 2020

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

1 reference

12 December 2020

Oral oseltamivir treatment of influenza in children.

1 reference

12 December 2020

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

1 reference

12 December 2020

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

1 reference

12 December 2020

Pharmacoeconomic assessment of oseltamivir in treating influenza--the case of otherwise healthy Danish adolescents and adults

1 reference

12 December 2020

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

1 reference

12 December 2020

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

1 reference

12 December 2020

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

12 December 2020

Health outcomes among patients receiving oseltamivir.

1 reference

12 December 2020

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

1 reference

12 December 2020

Community-acquired pneumonia. A prospective outpatient study

1 reference

12 December 2020

The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

1 reference

12 December 2020

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

1 reference

12 December 2020

Early administration of oral oseltamivir increases the benefits of influenza treatment

1 reference

12 December 2020

Use of influenza antivirals during 2003-2004 and monitoring of neuraminidase inhibitor resistance

1 reference

12 December 2020

The impact of influenza epidemics on hospitalizations.

1 reference

12 December 2020

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

1 reference

12 December 2020

Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

1 reference

12 December 2020

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

1 reference

12 December 2020

Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness

1 reference

12 December 2020

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

1 reference

12 December 2020

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

12 December 2020

The threat of an avian influenza pandemic.

1 reference

12 December 2020

Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly

1 reference

12 December 2020

Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment

1 reference

12 December 2020

10.2165/00019053-200624040-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

20 June 2017

1008051689

0 references

1 reference